Yahoo
Nasdaq - Delayed Quote USD

Fidelity Select Pharmaceuticals Port (FPHAX)

37.58 +1.14 (+3.13%)
At close: 8:10:03 PM EDT

Top 10 Holdings (72.07% of Total Assets)

Symbol Company % Assets
LLY 24.47%
GSK 7.92%
MRK 6.37%
VTRS 5.46%
AZN.L 4.98%
UCB.BR 4.96%
BMY 4.61%
ROP.SW 4.57%
GILD 4.47%
ELAN 4.26%

Sector Weightings

Overall Portfolio Composition (%)

Cash 1.05%
Stocks 98.44%
Bonds 0.08%
Others 0.43%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average FPHAX Category Average
Price/Earnings
0.04 24.55
Price/Book
0.21 5.28
Price/Sales
0.23 2.06
Price/Cashflow
0.06 17.54
Median Market Cap
118,187.81 34,862.81
3 Year Earnings Growth
28.09 32.48

Bond Holdings

Average FPHAX Category Average
Maturity
-- --
Duration
6 --
Credit Quality
-- --

Performance & Risk

YTD Return 20.44%
5y Average Return 14.64%
Rank in Category (ytd) 44
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.71
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Fidelity Investments
Net Assets 1.61B
YTD Return 13.94%
Yield 2.55%
Morningstar Rating
Inception Date Jun 18, 2001

Fund Summary

The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

Top Mutual Funds

Mobilize your Website
View Site in Mobile | Classic
Share by: